J B Chemicals & Pharmaceuticals : Disclosure of material event/information - Resignation of Chief Financial Officer
August 31, 2021 at 08:12 am EDT
Share
August 31, 2021
BSE Ltd.
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai 400 001
BSE Scrip Code: 506943
Stock Symbol: JBCHEPHARM
Dear Sir,
Sub: Disclosure under (i) Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the Securities and Exchange Board of India circular bearing reference no. CIR/CFD/CMD/4/2015 dated September 9, 2015 and (ii) Code of practices and procedure for disclosure of UPSI
Ref: Change in Key Managerial Personnel
Pursuant to Para A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Vijay Bhatt, Chief Financial Officer of the Company, has resigned from the services of the Company and shall cease to be the Chief Financial Officer of the Company from August 31, 2021 after the end of working hours.
As soon as the appointment of new Chief Financial Officer is made, we will notify the exchange.
We request you to take the above disclosure on record.
Thanking You,
Yours faithfully,
For J. B. Chemicals & Pharmaceuticals Ltd.
Sandeep
Anil
Phadnis
Digitally signed by Sandeep Anil Phadnis DN: c=IN, o=Personal, 2.5.4.20=3cf6eb0200f976a58369e39fde8b 8876481484d38598145f6e21f446bb743f2 e, postalCode=411038, st=Maharashtra, serialNumber=cc500fdd638e71336fc58b2 04e2ba05ea7c4ade49b8fe438e8f254c300 dec735, cn=Sandeep Anil Phadnis
JB Chemicals & Pharmaceuticals Ltd. published this content on 31 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 August 2021 12:11:09 UTC.
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.
J. B. CHEMICALS & PHARMACEUTICALS LIMITED 
